Allergies News and Research

Latest Allergies News and Research

Trius Therapeutics awarded $28 million to develop novel drugs targeting bacterial DNA Gyrase and Topoisomerase IV

Trius Therapeutics, Inc., today announced the award of a $28 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, for the development of novel antibiotics directed against multiple Gram-negative bacterial pathogens.

22 Oct 2008

FDA approves Astepro, new formulation of Astelin

The U.S. Food and Drug Administration (FDA) has approved Astepro - the new formulation of Astelin. Astepro Nasal Spray is an improvement over the marketed Astelin Nasal Spray and is better tolerated by patients using the new spray.

19 Oct 2008

Medication error rates to be reduced by technology

The use of new information technology could significantly reduce the number of drug-related injuries in Australian hospitals, according to Professor Johanna Westbrook.

16 Oct 2008

Breast is best in fight against childhood asthma

A University of Sunderland academic has discovered a link between breast feeding and a lower incidence in asthma in young children.

14 Oct 2008

Antiretroviral drug efavirenz associated with better outcomes in HIV-infected adults

A study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that HIV-infected patients taking the antiretroviral drug efavirenz were more likely to adhere to treatment and less likely to experience virologic failure and death compared to patients taking nevirapine.

14 Oct 2008

Use of oral vitamin D supplements may help prevent eczema

A study led by researchers at the University of California, San Diego School of Medicine suggests that use of oral Vitamin D supplements bolsters production of a protective chemical normally found in the skin, and may help prevent skin infections that are a common result of atopic dermatitis, the most common form of eczema.

6 Oct 2008

100 years of HIV in humans

HIV has existed among human populations for about 100 years, decades earlier than previously believed, according to a study published Wednesday in the journal Nature, the Los Angeles Times reports (Engel, Los Angeles Times, 10/2).

5 Oct 2008

DNA of good bacteria drives intestinal response to infection

A new study shows that the DNA of so-called "good bacteria" that normally live in the intestines may help defend the body against infection.

2 Oct 2008

When particles are so small that they seep right through skin

Scientists are finding that particles that are barely there - tiny objects known as nanoparticles that have found a home in electronics, food containers, sunscreens, and a variety of applications - can breech our most personal protective barrier: The skin.

30 Sep 2008

Science backs old fashioned belief in the healing powers of honey

Research by Canadian scientists lends support to the old fashioned belief in the healing powers of honey.

25 Sep 2008

New research blames pollution and everyday allergens for laryngitis

Researchers say everyday exposure to environmental tobacco smoke, allergens and air pollution may be the root of chronic cases of laryngitis.

23 Sep 2008

House members send letter to Condoleezza Rice requesting information on antiretrovirals supplied to PEPFAR by Ranbaxy

Rep. John Dingell (D-Mich.) and members of the House Committee on Energy and Commerce on Friday sent a letter to Secretary of State Condoleezza Rice requesting information about alleged safety problems with antiretrovirals manufactured by the Indian generic pharmaceutical company Ranbaxy and distributed through the President's Emergency Plan for AIDS Relief, the AP/International Herald Tribune reports (AP/International Herald Tribune, 9/19).

22 Sep 2008

Paracetamol-based medicines linked to asthma in children

A large international study has discovered a strong link between infant exposure to paracetamol and the development of asthma and other allergic conditions such as eczema.

22 Sep 2008

Genetic screening effective for initial HIV treatment

A major study from a team of researchers from Weill Cornell Medical College and Massachusetts General Hospital has found that a recent change to HIV-treatment guidelines recommending genetic screening is cost-effective under certain conditions. The new recommendation suggests conducting a genetic screening test prior to prescribing the drug abacavir, one of the preferred first-line drugs for the treatment for HIV-infected adults.

17 Sep 2008

FDA approves expanded uses for Gardasil for vaginal and vulvar cancer caused by HPV

The U.S. Food and Drug Administration has announced the approval of the vaccine Gardasil for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26.

14 Sep 2008

Schering-Plough launches Bridion (sugammadex) in Europe

Schering-Plough Corporation has announced that the European launch of Bridion (sugammadex) injection has begun with its introduction this week in Sweden, and that the product is expected to be available soon in the United Kingdom and Germany, with several other European markets to follow by the end of the year and in early 2009.

10 Sep 2008